These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1581625)
21. [Matti Ayräpää Award. Production of drug proteins in bioreactors]. Jänne J Duodecim; 1994; 110(21):1979-86. PubMed ID: 8654222 [No Abstract] [Full Text] [Related]
22. Antibody engineering: facing new challenges in cancer therapy. Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728 [TBL] [Abstract][Full Text] [Related]
23. [Ethical aspects of modern genetics]. Lisker R Rev Invest Clin; 1990; 42(1):63-7. PubMed ID: 2236976 [No Abstract] [Full Text] [Related]
24. [From cattle, swine, and horse insulin to human insulin: the biotechnology and genetic technology of insulin production]. Zündorf I; Dingermann T Pharm Unserer Zeit; 2001 Jan; 30(1):27-32. PubMed ID: 11233180 [No Abstract] [Full Text] [Related]
25. Discussions on human gene therapy. Milewski EA Recomb DNA Tech Bull; 1986 Jun; 9(2):88-130. PubMed ID: 3532218 [No Abstract] [Full Text] [Related]
27. [Transgenic, transplastomic and transient approaches for foreign gene expression in plants]. Kuchuk NV Tsitol Genet; 2007; 41(3):50-4. PubMed ID: 17649624 [TBL] [Abstract][Full Text] [Related]
28. Genetic engineering of human interferons from lymphoblastoid cells: II. Construction of trp expression plasmids and their use for efficient expression of IFN-alpha J1. Shafferman A; Cohen S; Grosfeld H; Leitner M; Velan B Adv Biotechnol Processes; 1985; 4():25-57. PubMed ID: 3902052 [No Abstract] [Full Text] [Related]
30. Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins. Abe H; Takaoka Y; Chiba Y; Sato N; Ohgiya S; Itadani A; Hirashima M; Shimoda C; Jigami Y; Nakayama K Glycobiology; 2009 Apr; 19(4):428-36. PubMed ID: 19129247 [TBL] [Abstract][Full Text] [Related]
31. The slow road to gene therapy. Weatherall DJ Nature; 1988 Jan; 331(6151):13-4. PubMed ID: 3422340 [No Abstract] [Full Text] [Related]
34. [Recent advances of heterologous gene expression in E. coli]. Zhao M; Zhang NH Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):226-30. PubMed ID: 12501640 [TBL] [Abstract][Full Text] [Related]
35. Engineering the gram-positive cell surface for construction of bacterial vaccine vectors. Oggioni MR; Medaglini D; Maggi T; Pozzi G Methods; 1999 Sep; 19(1):163-73. PubMed ID: 10525453 [TBL] [Abstract][Full Text] [Related]
36. [Genetic technology of substances important from the therapeutic and diagnostic aspects]. Srsen S Cesk Pediatr; 1989 Oct; 44(10):612-4. PubMed ID: 2620357 [No Abstract] [Full Text] [Related]
38. The role of the NIH in fostering leadership in biotechnology. Wyngaarden JB Recomb DNA Tech Bull; 1985 Sep; 8(3):94-7. PubMed ID: 3864202 [No Abstract] [Full Text] [Related]
39. [Drugs produced by genetic techniques. Current status and future perspectives. 4: Possible drug preparations by genetic techniques]. Hentze S Fortschr Med; 1991 Jan; 109(3):51-2. PubMed ID: 2026377 [No Abstract] [Full Text] [Related]
40. Response to Ivarie: Competitive bioreactor hens on the horizon. Etches RJ Trends Biotechnol; 2006 Mar; 24(3):101-2. PubMed ID: 16448712 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]